bioMérieux Share Price Euronext Paris
Equities
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.17B 334B | Sales 2025 * | 4.19B 4.48B 359B | Capitalization | 11.99B 12.82B 1,027B |
---|---|---|---|---|---|
Net income 2024 * | 466M 498M 39.9B | Net income 2025 * | 525M 561M 44.95B | EV / Sales 2024 * | 2.99 x |
Net cash position 2024 * | 308M 329M 26.36B | Net cash position 2025 * | 487M 521M 41.73B | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
26.1
x | P/E ratio 2025 * |
23.2
x | Employees | - |
Yield 2024 * |
0.86% | Yield 2025 * |
0.99% | Free-Float | 36.2% |
Latest transcript on bioMérieux
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 31/10/16 |
Chairman | 50 | 15/04/04 | |
Director of Finance/CFO | 47 | 28/02/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14/09/06 | |
Director/Board Member | 63 | 31/12/04 | |
Chairman | 50 | 15/04/04 |
1st Jan change | Capi. | |
---|---|---|
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B | |
-5.02% | 1.64B |